Free Trial

ST Germain D J Co. Inc. Increases Holdings in Danaher Corporation $DHR

Danaher logo with Medical background

Key Points

  • ST Germain D J Co. Inc. has significantly increased its holdings in Danaher Corporation by 812.7%, owning 38,306 shares valued at approximately $7.57 million as of the second quarter.
  • Danaher Corporation recently announced a quarterly dividend of $0.32 per share, with the payment date set for October 31st. This translates to an annualized dividend yield of 0.7%.
  • The company reported an EPS of $1.80 for its last quarter, surpassing analysts' expectations by $0.16, and has set its FY 2025 guidance at 7.700-7.800 EPS.
  • Interested in Danaher? Here are five stocks we like better.

ST Germain D J Co. Inc. grew its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 812.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,306 shares of the conglomerate's stock after acquiring an additional 34,109 shares during the period. ST Germain D J Co. Inc.'s holdings in Danaher were worth $7,567,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also made changes to their positions in DHR. Ameriflex Group Inc. purchased a new position in shares of Danaher in the fourth quarter valued at about $38,000. Park Square Financial Group LLC bought a new stake in shares of Danaher in the fourth quarter worth about $49,000. Centaurus Financial Inc. increased its holdings in shares of Danaher by 47.9% in the fourth quarter. Centaurus Financial Inc. now owns 13,208 shares of the conglomerate's stock worth $3,032,000 after purchasing an additional 4,276 shares during the last quarter. Fire Capital Management LLC bought a new stake in shares of Danaher in the fourth quarter worth about $823,000. Finally, MassMutual Private Wealth & Trust FSB increased its holdings in shares of Danaher by 8.2% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 109,208 shares of the conglomerate's stock worth $22,388,000 after purchasing an additional 8,293 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the company's stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Trading Down 2.3%

DHR opened at $181.56 on Friday. The stock has a market cap of $130.01 billion, a price-to-earnings ratio of 38.63, a P/E/G ratio of 2.65 and a beta of 0.75. The stock's 50 day moving average price is $199.54 and its 200-day moving average price is $197.72. Danaher Corporation has a one year low of $171.00 and a one year high of $279.90. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. The firm had revenue of $5.94 billion for the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. Danaher's dividend payout ratio is currently 27.23%.

Analyst Upgrades and Downgrades

DHR has been the topic of several research reports. Robert W. Baird lifted their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a report on Friday, July 18th. Bank of America reduced their target price on Danaher from $230.00 to $220.00 and set a "buy" rating on the stock in a report on Monday. Guggenheim reaffirmed a "buy" rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, July 23rd. Evercore ISI reduced their price objective on Danaher from $230.00 to $226.00 and set an "outperform" rating on the stock in a research note on Tuesday, July 8th. Finally, Royal Bank Of Canada set a $241.00 price objective on Danaher in a research note on Tuesday, September 2nd. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average price target of $245.91.

Get Our Latest Stock Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Danaher Right Now?

Before you consider Danaher, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.

While Danaher currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.